Enzalutamide (Xtandi) capsules treats patients with metastatic castration-resistant prostate cancer.
Tony Berberabe, MPH, OncLive
Advertisement
Articles by Tony Berberabe, MPH, OncLive
Advertisement
Latest Updated Articles
FDA to Review NDA for Metastatic Prostate Cancer DrugPublished: February 24th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
4
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
5
